HomeClinical TopicsCardio-PulmonaryFDA allows marketing of first system to repair failed or problematic aortic...

FDA allows marketing of first system to repair failed or problematic aortic endografts

The U.S. Food and Drug Administration is allowing marketing of the first system—a minimally invasive option—that can repair a failed or problematic aortic endograft. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...